Clinical trial
Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I
NCT00004333 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I
- Lead sponsor
- National Center for Research Resources (NCRR)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 1994
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
tyrosinemia, type i